All Posts Tagged With: "promotion"
Pfizer Pulls Doctor Ad for Lipitor
Pfizer said today that it was pulling the plug on advertising that features Robert Jarvik, M.D., promoting the benefit of atorvastatin (Lipitor).
The Pfizer decision was included in a letter to Reps. John D. Dingell (D-Mich.), chairman of the Committee on Energy and Commerce, and Bart Stupak (D-Mich.) chairman of the Subcommittee on Oversight and [...]
Popularity: 40% [?]
25Feb2008 | PharmaWatchDog | 0 comments | Continued
FDA to Permit Promotion of Off-Label Use
FDA draft guidelines issued today would permit the marketing of FDA-approved drugs and devices by the use of scientific reprints that discuss unapproved indications — currently a forbidden practice.The draft guidelines, entitled “Good Reprint Practices,” are now subject to a 60-day public comment period.
But before they even hit the Federal Register, the draft guidelines drew [...]
Popularity: 47% [?]
17Feb2008 | PharmaWatchDog | 0 comments | Continued
ALERT - PROTECT YOUR HEALTH
The FDA is considering a policy change that would allow pharmaceutical companies to give physicians journal articles that detail off-label uses of drugs, according to Rep. Henry Waxman (D-Calif).
If approved, the FDA proposal “would allow drug and device companies to short-circuit FDA review and approval by sponsoring drug trials that are carefully constructed to deliver [...]
Popularity: 42% [?]
16Feb2008 | PharmaWatchDog | 0 comments | Continued
Drug Ads Raise Questions for Heart Pioneer
Dr. Robert Jarvik is best known for the artificial heart he pioneered more than a quarter-century ago. Since then he had toiled in relative obscurity — until he began appearing in television ads two years ago for the Pfizer cholesterol drug Lipitor.
The ads have depicted him, among other outdoorsy pursuits, rowing a one-man racing shell [...]
Popularity: 45% [?]
7Feb2008 | PharmaWatchDog | 0 comments | Continued
New Marketing Opportunity for Big Pharma
Our government and big pharma = perfect together.
The government has published guidance promoting partnerships between the National Health Service and the pharmaceutical industry, in a new tactic to improve patient care and help the service meet the rapidly changing demands of the 21st century.
Given its extensive knowledge on illnesses and innovative medicines, the industry certainly [...]
Popularity: 35% [?]
5Feb2008 | PharmaWatchDog | 0 comments | Continued
Nurses Are “Soft Targets” For Drug Companies’ Promotional Tactics
Nursing education fails to prepare graduates to deal with the pharmaceutical industry’s promotional tactics, and many nurses appear to accept promotional materials uncritically, according to an analysis of the nursing literature published in PLoS Medicine.
“The pharmaceutical industry recognizes nursing influence on medical prescribing and identifies nurses as a marketing target,” say the authors, Annemarie Jutel [...]
Popularity: 44% [?]
5Feb2008 | PharmaWatchDog | 0 comments | Continued
Pharmaceutical Company Influence on our Teaching Centers
About 60% of department heads at medical schools and teaching hospitals in the U.S. have personal financial relationships with pharmaceutical or medical device companies, according to a study published on Wednesday in the Journal of the American Medical Association. Researchers sent a survey to department heads at all 125 accredited medical schools and [...]
Popularity: 43% [?]
18Oct2007 | PharmaWatchDog | 0 comments | Continued
March of the Clones
For those of you who don’t know, when a drug is approved by the Federal Food and Drug Administration (FDA) it receives an indication which specifies its use. In order to maximize the profitability of their drugs, pharmaceutical companies initiate new clinical trials or sponsor research to search for additional indications and, if the [...]
Popularity: 47% [?]
17Sep2007 | PharmaWatchDog | 1 comment | Continued
